Trial intelligence / Profile preview

Scalp Nerve Block for Emergence Agitation in Children

NCT02428283Phase 4Completed

Sponsor
Ajou University School of Medicine
Start
May 2015
Primary completion
Nov 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine in Emergence agitation (EA), sponsored by Ajou University School of Medicine. Started May 2015; status: completed.

02

Drugs

ropivacaine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT02428283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02428283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call